guest ::
| Home > Institute Collections > W500 > Tumor- and host-derived heparanase-2 (Hpa2) attenuates tumorigenicity: role of Hpa2 in macrophage polarization and BRD7 nuclear localization. |
| Home > Institute Collections > W500 > Tumor- and host-derived heparanase-2 (Hpa2) attenuates tumorigenicity: role of Hpa2 in macrophage polarization and BRD7 nuclear localization. |
| Journal Article | DKFZ-2025-02479 |
; ; ; ; ; ; ; ; ; ; ; ;
2024
Nature Publishing Group
London [u.a.]
Abstract: Little attention was given to heparanase 2 (Hpa2) over the last two decades, possibly because it lacks a heparan sulfate (HS)-degrading activity typical of heparanase. Emerging results suggest, nonetheless, that Hpa2 plays a role in human pathologies, including cancer progression where it functions as a tumor suppressor. Here, we examined the role of Hpa2 in cervical carcinoma. We report that high levels of Hpa2 correlate with prolonged survival of cervical carcinoma patients. Strong staining intensity of Hpa2 also correlates with low tumor grade. Overexpression of Hpa2 in SiHa cervical carcinoma cells resulted in tumor xenografts that were two-fold smaller than control tumors. Interestingly, even smaller tumor xenografts were developed by SiHa cells overexpressing the Pro140Arg and Asn543Ile Hpa2 missense mutations that were identified in patients diagnosed with urofacial syndrome (UFS). Utilizing the Ras recruitment system, we identified bromodomain-containing protein 7 (BRD7) to interact with Hpa2 and found that both BRD7 and the Hpa2 mutants are translocated to the cell nucleus in tumors developed by the Pro140Arg and Asn543Ile Hpa2 mutants. Utilizing our newly developed conditional Hpa2-KO mice, we further show that Hpa2 plays a critical role in macrophage polarization; in the absence of Hpa2, macrophages are shifted towards pro-tumorigenic, M2 phenotype. Notably, implanting SiHa cervical carcinoma cells together with Hpa2-KO macrophages promoted tumor growth. These results support, and further expand, the notion that Hpa2 functions as a tumor suppressor, co-operating with another tumor suppressor, BRD7.
Keyword(s): Humans (MeSH) ; Animals (MeSH) ; Female (MeSH) ; Glucuronidase: metabolism (MeSH) ; Glucuronidase: genetics (MeSH) ; Uterine Cervical Neoplasms: pathology (MeSH) ; Uterine Cervical Neoplasms: genetics (MeSH) ; Uterine Cervical Neoplasms: metabolism (MeSH) ; Macrophages: metabolism (MeSH) ; Cell Nucleus: metabolism (MeSH) ; Mice (MeSH) ; Cell Line, Tumor (MeSH) ; Carcinogenesis: pathology (MeSH) ; Carcinogenesis: metabolism (MeSH) ; Carcinogenesis: genetics (MeSH) ; Glucuronidase ; heparanase
; 
; 
; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
